Arcellx Share Price Today
(NASDAQ: ACLX)

Name: Arcellx Share Price Today (NASDAQ: ACLX) - Arcellx Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Arcellx share price is $68.13 & ₹5,902.78 as on 1 Feb 2025, 2.30 'hrs' IST

$68.13

▲

0.55

(0.81%)

Market is closed - opens 8 PM, 03 Feb 2025

View live Arcellx share price in Dollar and Rupees. Guide to invest in Arcellx stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Arcellx, along with analyst recommendations, forecasts, and comprehensive financials.

Arcellx share price movements

Today's Low: $67.36
Today's High: $70.24
$68.13
1.14%
Downside
Day's Volatility :4.11%
Upside
3.0%
52 Weeks Low: $47.88
52 Weeks High: $107.37
$68.13
29.72%
Downside
52 Weeks Volatility :55.41%
Upside
36.55%

Arcellx (ACLX) Returns

Period	Arcellx, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-21.18%	-0.6%	0.0%
6 Months	33.35%	-2.8%	0.0%
1 Year	7.22%	3.3%	0.0%
3 Years	305.54%	11.6%	-13.7%

Arcellx (ACLX) Key Statistics

in dollars & INR

Previous Close	$67.58
Open	$67.69
Today's High	$70.24
Today's Low	$67.355
Market Capitalization	$3.7B
Today's Volume	$810.0K
52 Week High	$107.3699
52 Week Low	$47.88
Revenue TTM	$155.8M
EBITDA	$-65.3M
Earnings Per Share (EPS)	$-0.71
Profit Margin	-25.94%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-10.79%

How to invest in Arcellx Stock (ACLX) from India?

It is very easy for Indian residents to invest directly in Arcellx from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Arcellx stock in both Indian Rupees (INR) and US Dollars (USD). Search for Arcellx or ACLX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Arcellx or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Arcellx shares which would translate to 0.013 fractional shares of Arcellx as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Arcellx, in just a few clicks!

Returns in Arcellx (ACLX) for Indian investors in Rupees

The Arcellx stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Arcellx investment value today

Current value as on today

₹1,11,783

Returns

₹11,783

(+11.78%)

Returns from Arcellx Stock

₹7,224 (+7.22%)

Dollar Returns

₹4,559 (+4.56%)

Indian investors sentiment towards Arcellx (ACLX)

-44%

Period: Jan 1, 2025 to Jan 31, 2025. Change in 30 Days versus previous period

Search interest for Arcellx Stock from India on INDmoney has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Arcellx

FMR Inc
11.98%
BlackRock Inc
7.85%
Paradigm Biocapital Advisors LP
7.40%
Perceptive Advisors LLC
7.19%
NEA Management Company, LLC
6.93%
Vanguard Group Inc
4.55%

Analyst Recommendation on Arcellx

Buy

95%Buy

4%Hold

0%Sell

Based on 21 Wall street analysts offering stock ratings for Arcellx(by analysts ranked 0 to 5 stars)

Based on 21 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Arcellx Stock (ACLX)

What analysts predicted

Upside of 70.81%

Target:

$116.38

Current:

$68.13

Insights on Arcellx Stock (Ticker Symbol: ACLX)

Price Movement
In the last 7 days, ACLX stock has moved up by 8.2%
ACLX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 55.1% return, outperforming this stock by 48.3%
Price to Sales
ForACLX every $1 of sales, investors are willing to pay $22.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.4 for every $1 of sales.

Arcellx Technicals Summary

Sell

Neutral

Buy

Arcellx is currently in a neutral trading position according to technical analysis indicators.

Arcellx (ACLX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Arcellx, Inc.	-13.49%	33.35%	7.22%	305.54%	305.54%
Biontech Se	7.35%	57.95%	33.59%	-31.3%	308.89%
Regeneron Pharmaceuticals, Inc.	-5.9%	-37.18%	-28.8%	8.05%	97.29%
Vertex Pharmaceuticals Incorporated	13.78%	-3.19%	8.71%	82.07%	100.29%
Alnylam Pharmaceuticals, Inc.	16.13%	2.38%	56.77%	86.78%	136.62%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Arcellx, Inc.	NA	NA	NA	-1.5	-0.11	-0.06	NA	8.95
Biontech Se	160.8	NA	0.04	-3.32	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	16.89	16.89	1.06	44.96	0.17	0.07	NA	272.04
Vertex Pharmaceuticals Incorporated	32.84	NA	1.15	0.49	-0.03	0.12	NA	60.65
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.18	-15.01	-0.03	NA	0.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Arcellx, Inc.	Buy	$3.7B	305.54%	NA	-25.94%
Biontech Se	Buy	$29.0B	308.89%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$75.1B	97.29%	16.89	33.61%
Vertex Pharmaceuticals Incorporated	Buy	$112.9B	100.29%	32.84	-4.51%
Alnylam Pharmaceuticals, Inc.	Buy	$35.7B	136.62%	NA	-15.86%

Arcellx Dividend announcements

Arcellx Earnings
Arcellx’s price-to-earnings ratio stands at None
Read More

About Arcellx

Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States. The company's lead ddCAR product candidate is anitocabtagene autoleucel, which is in phase 2 clinical trial for the treatment of patients with relapsed or refractory multiple myeloma (rrMM). It also develops ACLX-001, a product candidate in Phase 1 clinical trials targeting BCMA to treat rrMM; and ACLX-002, which is in Phase 1 clinical trials that targets CD123 for treating relapsed or refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). In addition, the company's preclinical product includes ACLX-003 for the treatment of AML and MDS. Further, it focuses on the development of product candidates for solid tumor programs. It has a strategic alliance with Kite Pharma, Inc. to co-develop and co-commercialize anitocabtagene autoleucel. The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016. Arcellx, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Organization	Arcellx
Employees	130
CEO	Mr. Rami Elghandour
Industry	Healthcare

Management People of Arcellx

Name	Title
Mr. Rami Elghandour	Chairman of the Board, CEO & President
Ms. Michelle Lim Gilson	Chief Financial Officer
Dr. Christopher R. Heery M.D.	Chief Medical Officer
Mr. Narinderjeet Singh M.S.	Chief Technical Officer
Dr. Heba Nowyhed Ph.D.	Chief Scientific Officer
Ms. Myesha Lacy	Chief Investor & Communications Officer
Ms. Maryam Abdul-Kareem J.D., M.S.	General Counsel & Chief Legal Officer
Ms. Kate Aiken	Chief People Officer
Mr. Neeraj P. Teotia	Chief Commercial Officer
Ms. Aileen Fernandes	Chief Business Officer

Important FAQs about investing in ACLX Stock from India :

What is Arcellx share price today?

Arcellx share price today stands at $68.13, Open: $67.69 ; Previous Close: $67.58 ; High: $70.24 ; Low: $67.36 ; 52 Week High: $107.37 ; 52 Week Low: $47.88.

The stock opens at $67.69, after a previous close of $67.58. The stock reached a daily high of $70.24 and a low of $67.36, with a 52-week high of $107.37 and a 52-week low of $47.88.

Can Indians buy Arcellx shares?

Yes, Indians can invest in the Arcellx (ACLX) from India.

With INDmoney, you can buy Arcellx at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Arcellx at zero transaction cost.

How can I buy Arcellx shares from India?

It is very easy to buy Arcellx from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Arcellx (ACLX) be purchased?

Yes, you can buy fractional shares of Arcellx with INDmoney app.

What are the documents required to start investing in Arcellx stocks?

To start investing in Arcellx, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.